This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Brunello A et al. (2005) Adjuvant chemotherapy for elderly patients (≥70 years) with early, high risk breast cancer: a retrospective analysis of 260 patients. Ann Oncol 16: 1276–1282
Basso U and Monfardini S (2004) Multidimensional geriatric evaluation in elderly cancer patients: a practical approach. Eur J Cancer Care 13: 424–433
Early Breast Cancer Trialists' Collaborative Group (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview. Lancet 365: 1687–1717
Fargeot P et al. (2004) Disease-free survival advantage of weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients: 6-year follow-up results of the French Adjuvant Study Group 08 Trial. J Clin Oncol 22: 4674–4682
Acknowledgements
The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Monfardini, S., Basso, U. Do older women with breast cancer benefit from adjuvant chemotherapy?. Nat Rev Clin Oncol 3, 652–653 (2006). https://doi.org/10.1038/ncponc0671
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncponc0671